Please use this identifier to cite or link to this item:
Title: Disruption of the RNA Modifications That Target the Ribosome Translation Machinery in Human Cancer
Author: Janin, Maxime
Coll-SanMartin, Laia
Esteller, Manel
Keywords: RNA
Issue Date: 2-Apr-2020
Publisher: BioMed Central
Abstract: Genetic and epigenetic changes deregulate RNA and protein expression in cancer cells. In this regard, tumors exhibit an abnormal proteome in comparison to the corresponding normal tissues. Translation control is a crucial step in the regulation of gene expression regulation under normal and pathological conditions that ultimately determines cellular fate. In this context, evidence shows that transfer and ribosomal RNA (tRNA and rRNA) modifications affect the efficacy and fidelity of translation. The number of RNA modifications increases with the complexity of organisms, suggesting an evolutionary diversification of the possibilities for fine-tuning the functions of coding and non-coding RNAs. In this review, we focus on alterations of modifications of transfer and ribosomal RNA that affect translation in human cancer. This variation in the RNA modification status can be the result of altered modifier expression (writers, readers or erasers), but also due to components of the machineries (C/D or H/ACA boxes) or alterations of proteins involved in modifier expression. Broadening our understanding of the mechanisms by which site-specific modifications modulate ribosome activity in the context of tumorigenesis will enable us to enrich our knowledge about how ribosomes can influence cell fate and form the basis of new therapeutic opportunities.
Note: Reproducció del document publicat a:
It is part of: Molecular Cancer, 2020, vol. 19, num. 70
Related resource:
ISSN: 1476-4598
Appears in Collections:Articles publicats en revistes (Ciències Fisiològiques)

Files in This Item:
File Description SizeFormat 
700890.pdf968.65 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons